How much does it cost to buy Aducanumab in RMB?

Aducanumab (Aducanumab) is indicated for the treatment of Alzheimer's disease. Treatment should be initiated in patients with mild cognitive impairment or mild dementia stages of the disease for whom treatment is initiated in clinical trials. There are no safety or efficacy data regarding initiation of treatment earlier or later in the disease stage than studied. Aducanumab’s original drug is not marketed in China. It is currently relatively expensive when it is marketed overseas, and the purchase conditions are restricted. The drug's initial price of $56,000 per year is expected to double or triple the cost at even modest doses; restrictions on aducanumab's use have resulted in its price being halved to $28,200 per year by December 2021.